Cargando…
Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics
Numerous studies have confirmed that cancer stem cells (CSCs) are more resistant to chemotherapy; however, there is a paucity of data exploring the effect of long-term drug treatment on the CSC sub-population. The purpose of this study was to investigate whether long-term doxorubicin treatment could...
Autores principales: | Zheng, X, Naiditch, J, Czurylo, M, Jie, C, Lautz, T, Clark, S, Jafari, N, Qiu, Y, Chu, F, Madonna, M B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730434/ https://www.ncbi.nlm.nih.gov/pubmed/23887631 http://dx.doi.org/10.1038/cddis.2013.264 |
Ejemplares similares
-
The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012) -
Midkine Mediates Intercellular Crosstalk between Drug-Resistant and Drug-Sensitive Neuroblastoma Cells In Vitro and In Vivo
por: Chu, Fei, et al.
Publicado: (2013) -
Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015) -
Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells
por: Lee, Sook-Jeong, et al.
Publicado: (2014)